Chinese Journal of Pharmaceuticals
|
2023, 54(8): 1269-1272
• Pharmaceutical Management & Information •
Implementation and Optimization of the Policy of Encouraging R&D and Declaring the Medicine List for Children in China
Full
Qian WANG
1, Haoyu YANG
1, Feng JIANG
1, Shengming WANG
1, Kan TIAN
2, *, Shiyu XIE
2
Affiliations
- 1.School of Health Economics Management, Nanjing University of Chinese Medicine, Nanjing 210023
- 2.School of Elderly Care Service and Management, Nanjing University of Chinese Medicine, Nanjing 210023
Published: 2023-08-10
doi: 10.16522/j.cnki.cjph.2023.08.019
Outline
王乾, 杨浩宇, 蒋丰, 王圣鸣, 田侃, 谢士钰.
我国《鼓励研发申报儿童药品清单》的政策实施效果及优化.
中国医药工业杂志,
2023
, 54
(8)
: 1269
-1272
.
DOI: 10.16522/j.cnki.cjph.2023.08.019
Qian WANG, Haoyu YANG, Feng JIANG, Shengming WANG, Kan TIAN, Shiyu XIE.
Implementation and Optimization of the Policy of Encouraging R&D and Declaring the Medicine List for Children in China[J].
Chinese Journal of Pharmaceuticals,
2023
, 54
(8)
: 1269
-1272
.
DOI: 10.16522/j.cnki.cjph.2023.08.019
Year 2023 volume 54 Issue 8
15
3
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2023.08.019
- Receive Date:2023-03-31
- Online Date:2026-11-19
- Published:2023-08-10